L65.1

Anagen effluvium

Billable code

This code does not map to a risk-adjusting HCC in the loaded models.

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

Inherited from L65Other nonscarring hair loss
Excludes 1

trichotillomania (F63.3)

Use additional

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Inherited from L60-L75Disorders of skin appendages
Excludes 1

congenital malformations of integument (Q84.-)

Inherited from chapter 12Diseases of the skin and subcutaneous tissue
Excludes 2

certain conditions originating in the perinatal period (P04-P96) certain infectious and parasitic diseases (A00-B99) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) lipomelanotic reticulosis (I89.8) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) systemic connective tissue disorders (M30-M36) viral warts (B07.-)

Official Guidelines for L65.1

FY 2026 ›
I.C.12Chapter-specific guidanceChapter 12: Diseases of the Skin and Subcutaneous Tissue

Subsections

Find L65.1 in the alphabetic index

1 index path leads to this code